TriSalus Life Sciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
TriSalus Life Sciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2020 to Q2 2023.
  • TriSalus Life Sciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was $478K, a 82.3% decline year-over-year.
  • TriSalus Life Sciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was $3.55M, a 72.5% decline year-over-year.
  • TriSalus Life Sciences, Inc. annual Nonoperating Income (Expense) for 2022 was $8.86M, a 13.4% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $3.55M $478K -$2.23M -82.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $5.77M $422K -$3.08M -88% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $8.86M $1.36M -$2.67M -66.2% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-22
Q3 2022 $11.5M $1.28M -$1.39M -52% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $12.9M $2.7M +$1.54M +132% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $11.4M $3.51M +$3.57M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $7.81M $4.04M +$4.64M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $3.17M $2.67M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.16M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$64K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$603K Sep 11, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.